Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100136303 | 10013630 | 3 | F | 201402 | 20140311 | 20140315 | 20140331 | PER | US-009507513-1403USA001296 | MERCK | 70.03 | YR | F | Y | 77.98000 | KG | 20140331 | N | CN | CA | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100136303 | 10013630 | 1 | PS | OXYTROL FOR WOMEN | 1 | TRANSDERMAL | 1 DF, Q4D | D | 3C01WS | 202211 | 1 | DF | TRANSDERMAL PATCH | ||||||
| 100136303 | 10013630 | 2 | C | OLMETEC | 1 | UNK, UNKNOWN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100136303 | 10013630 | 1 | Hypertonic bladder |
| 100136303 | 10013630 | 2 | Hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100136303 | 10013630 | Application site erythema | |
| 100136303 | 10013630 | Application site pruritus | |
| 100136303 | 10013630 | Drug ineffective | |
| 100136303 | 10013630 | Product adhesion issue | |
| 100136303 | 10013630 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100136303 | 10013630 | 1 | 20140204 | 20140216 | 0 |